A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease
Clinical Ophthalmology, September 2021
David McMullin, David Clark, Bill Cavanagh, Paul Karpecki, Todd C Brady
The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||6||100%|
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||1||11%|
|Readers by discipline||Count||As %|
|Nursing and Health Professions||1||11%|
|Medicine and Dentistry||1||11%|
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2021.
All research outputs
of 23,018,998 outputs
Outputs from Clinical Ophthalmology
of 3,234 outputs
Outputs of similar age
of 427,576 outputs
Outputs of similar age from Clinical Ophthalmology
of 93 outputs
Altmetric has tracked 23,018,998 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,234 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,576 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.